Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Information about LCT Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


June 5, 2008
LCT Expands Diabetes Clinical Trial
June 3, 2008
LCT Lists on International OTCQX
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
May 12, 2008
LCT presents encapsulation technology at conference
May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
 

Stroke

Stroke (also known as cerebrovascular disease) occurs when the supply of blood to the brain is suddenly disrupted. Blood may stop moving through an artery because the artery is blocked by a blood clot or plaque, or because the artery breaks or bursts.

When blood is stopped, the brain cannot get the oxygen it needs. Brain cells in the area die and the brain can become permanently damaged. Whilst stroke is more common amongst the elderly, it is not isolated to this age bracket. Over 50% of strokes are under the age of 75 years with around 5% of strokes under the age of 45 years.

  • Stroke is the third largest cause of death and one of the leading causes of disability amongst adults in Australia.
  • Over 48,000 strokes occur in Australia every year. With the ageing population this number will rise to a staggering 74,000 by the year 2017 if nothing is done in prevention of stroke.
  • Of the 48,000 people that experience a stroke each year, one third will die in the first 12 months.
  • Approximately 220,000 Australians who have suffered a stroke are living in the community.



LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd